Overcoming recruitment barriers revealed high readiness to participate and low dropout rate among people with schizophrenia in a randomized controlled trial testing the effect of a Guided Self-Determination intervention
- PMID: 24490977
- PMCID: PMC3927263
- DOI: 10.1186/1471-244X-14-28
Overcoming recruitment barriers revealed high readiness to participate and low dropout rate among people with schizophrenia in a randomized controlled trial testing the effect of a Guided Self-Determination intervention
Abstract
Background: Recruitment is one of the most serious challenges in performing randomized controlled trials. Often clinical trials with participants diagnosed with schizophrenia are terminated prematurely because of recruitment challenges resulting in a considerable waste of resources in the form of time, funding, and the participants' efforts. Dropout rates in schizophrenia trials are also high.Recruitment challenges are often due to patients not wanting to participate in research but can also be due to clinicians' concerns regarding individuals diagnosed with schizophrenia as participants in research. This paper reports how overcoming recruitment challenges not related to patients revealed high readiness to take part and low dropout rates in a one year long randomized controlled trial testing Guided Self-Determination (GSD) among outpatients with schizophrenia receiving treatment in Assertive Outreach Teams in the northern part of Denmark.
Methods: GSD is a shared decision-making and mutual problem-solving method using reflection sheets, which was developed in diabetes care and adjusted for this study and utilized by patients with schizophrenia. Descriptive data on strategies to overcome recruitment challenges were derived from notes and observations made during the randomized controlled trial testing of GSD in six outpatient teams.
Results: Three types of recruitment challenges not related to patients were identified and met during the trial: 1) organizational challenges, 2) challenges with finding eligible participants and 3) challenges with having professionals invite patients to participate. These challenges were overcome through: 1) extension of time, 2) expansion of the clinical recruitment area and 3) encouragement of professionals to invite patients to the study. Through overcoming these challenges, we identified a remarkably high patient-readiness to take part (101 of 120 asked accepted) and a low dropout rate (8%).
Conclusion: Distinction between recruitment challenges was important in discovering the readiness among patients with schizophrenia to take part in and complete a trial with the GSD-intervention.
Figures



Similar articles
-
Factors Associated With Dropout During Recruitment and Follow-Up Periods of a mHealth-Based Randomized Controlled Trial for Mobile.Net to Encourage Treatment Adherence for People With Serious Mental Health Problems.J Med Internet Res. 2017 Feb 21;19(2):e46. doi: 10.2196/jmir.6417. J Med Internet Res. 2017. PMID: 28223262 Free PMC article. Clinical Trial.
-
The Momentum trial: the efficacy of using a smartphone application to promote patient activation and support shared decision making in people with a diagnosis of schizophrenia in outpatient treatment settings: a randomized controlled single-blind trial.BMC Psychiatry. 2019 Jun 17;19(1):185. doi: 10.1186/s12888-019-2143-2. BMC Psychiatry. 2019. PMID: 31208376 Free PMC article. Clinical Trial.
-
Changes in persistent delusions in schizophrenia using guided self-determination: a single case study.Issues Ment Health Nurs. 2012 May;33(5):293-300. doi: 10.3109/01612840.2011.653624. Issues Ment Health Nurs. 2012. PMID: 22545636
-
Effects on cognitive and clinical insight with the use of Guided Self-Determination in outpatients with schizophrenia: A randomized open trial.Eur Psychiatry. 2015 Jul;30(5):655-63. doi: 10.1016/j.eurpsy.2014.12.007. Epub 2015 Jan 16. Eur Psychiatry. 2015. PMID: 25601635 Clinical Trial.
-
Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial.J Clin Psychiatry. 2019 Apr 23;80(3):18m12546. doi: 10.4088/JCP.18m12546. J Clin Psychiatry. 2019. PMID: 31050233 Clinical Trial.
Cited by
-
Attitudes of stakeholders in psychiatry towards the inclusion of children in genomic research.Hum Genomics. 2018 Mar 5;12(1):12. doi: 10.1186/s40246-018-0144-8. Hum Genomics. 2018. PMID: 29506557 Free PMC article.
-
Short Text Messages to Encourage Adherence to Medication and Follow-up for People With Psychosis (Mobile.Net): Randomized Controlled Trial in Finland.J Med Internet Res. 2017 Jul 12;19(7):e245. doi: 10.2196/jmir.7028. J Med Internet Res. 2017. PMID: 28701292 Free PMC article. Clinical Trial.
-
A Smartphone App to Foster Power in the Everyday Management of Living With Schizophrenia: Qualitative Analysis of Young Adults' Perspectives.JMIR Ment Health. 2018 Oct 1;5(4):e10157. doi: 10.2196/10157. JMIR Ment Health. 2018. PMID: 30274966 Free PMC article.
-
Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study.J Child Adolesc Psychopharmacol. 2015 Sep;25(7):535-47. doi: 10.1089/cap.2014.0164. J Child Adolesc Psychopharmacol. 2015. PMID: 26375767 Free PMC article. Clinical Trial.
-
Prediabetes and cardiovascular risk factors: the effectiveness of a guided self-determination counselling approach in primary health care, a randomized controlled trial.BMC Public Health. 2024 Nov 1;24(1):3035. doi: 10.1186/s12889-024-20538-1. BMC Public Health. 2024. PMID: 39487428 Free PMC article. Clinical Trial.
References
-
- de Salis I, Tomlin Z, Toerien M, Donovan J. Using qualitative research methods to improve recruitment to randomized controlled trials: the Quartet study. J Health Serv Res Policy. 2008;13(Suppl 3):92–96. - PubMed
-
- Ross S, Grant A, Counsell C, Gillespie W, Russell I, Prescott R. Barriers to participation in randomised controlled trials: a systematic review. J Clin Epidemiol. 1999;52(12):1143–1156. - PubMed
-
- Gilbody S, Wahlbeck K, Adams C. et al.Randomized controlled trials in schizophrenia: a critical perspective on the literature. Acta Psychiatr Scand. 2002;105:243–251. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous